FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 68001-468 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA204368
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20201209
Package count2

External sources

Source: openFDA. Public-domain (CC0).